(Q38374620)

English

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial (English)

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

Janusz Gumprecht

4

object named as

Janusz Gumprecht

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

author name string

Wendy Lane

1

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Timothy S Bailey

2

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Gregg Gerety

3

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Athena Philis-Tsimikas

5

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Charlotte Thim Hansen

6

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Thor S S Nielsen

7

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Mark Warren

8

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Group Information

9

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

SWITCH 1

10

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

language of work or name

0 references

publication date

1 July 2017

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

The Journal of the American Medical Association

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

318

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

1

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

33-44

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Increased mortality of patients with diabetes reporting severe hypoglycemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority tria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

31 August 2018

Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

31 August 2018

Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

31 August 2018

Severe hypoglycemia and risks of vascular events and death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

31 August 2018

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

31 August 2018

Risk of Cardiac Arrhythmias During Hypoglycemia in Patients With Type 2 Diabetes and Cardiovascular Risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

3 December 2018

Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/28672316

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1001/JAMA.2017.7115

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38374620&oldid=1756592495"